271 related articles for article (PubMed ID: 32145469)
1. Tissue Responses to Shiga Toxin in Human Intestinal Organoids.
Pradhan S; Karve SS; Weiss AA; Hawkins J; Poling HM; Helmrath MA; Wells JM; McCauley HA
Cell Mol Gastroenterol Hepatol; 2020; 10(1):171-190. PubMed ID: 32145469
[TBL] [Abstract][Full Text] [Related]
2. Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4.
Tran SL; Billoud L; Lewis SB; Phillips AD; Schüller S
Cell Microbiol; 2014 Aug; 16(8):1255-66. PubMed ID: 24612002
[TBL] [Abstract][Full Text] [Related]
3. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
[TBL] [Abstract][Full Text] [Related]
4. Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model.
Bova RA; Lamont AC; Picou TJ; Ho VB; Gilchrist KH; Melton-Celsa AR
Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977098
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
6. Molecular Biology of
Menge C
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
[TBL] [Abstract][Full Text] [Related]
8. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.
Petruzziello-Pellegrini TN; Yuen DA; Page AV; Patel S; Soltyk AM; Matouk CC; Wong DK; Turgeon PJ; Fish JE; Ho JJ; Steer BM; Khajoee V; Tigdi J; Lee WL; Motto DG; Advani A; Gilbert RE; Karumanchi SA; Robinson LA; Tarr PI; Liles WC; Brunton JL; Marsden PA
J Clin Invest; 2012 Feb; 122(2):759-76. PubMed ID: 22232208
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids.
Pradhan S; Weiss AA
mBio; 2020 Jul; 11(4):. PubMed ID: 32636253
[No Abstract] [Full Text] [Related]
10. Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli.
Karve SS; Pradhan S; Ward DV; Weiss AA
PLoS One; 2017; 12(6):e0178966. PubMed ID: 28614372
[TBL] [Abstract][Full Text] [Related]
11. Role of Shiga/Vero toxins in pathogenesis.
Obata F; Obrig T
Microbiol Spectr; 2014 Jun; 2(3):. PubMed ID: 25530918
[TBL] [Abstract][Full Text] [Related]
12. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.
Bellmeyer A; Cotton C; Kanteti R; Koutsouris A; Viswanathan VK; Hecht G
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G576-81. PubMed ID: 19556613
[TBL] [Abstract][Full Text] [Related]
13. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
Detzner J; Pohlentz G; Müthing J
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
[TBL] [Abstract][Full Text] [Related]
14. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection.
Cabrera G; Fernández-Brando RJ; Mejías MP; Ramos MV; Abrey-Recalde MJ; Vanzulli S; Vermeulen M; Palermo MS
Int J Med Microbiol; 2015 Dec; 305(8):910-7. PubMed ID: 26456732
[TBL] [Abstract][Full Text] [Related]
16. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157.
Kawano K; Okada M; Haga T; Maeda K; Goto Y
Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):227-32. PubMed ID: 18071766
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxins and stx phages: highly diverse entities.
Krüger A; Lucchesi PM
Microbiology (Reading); 2015 Mar; 161(Pt 3):451-62. PubMed ID: 25479836
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Enteroid Monolayers Model the Human Intestinal Environment for Escherichia coli Infection.
Small JT; Weiss AA
J Bacteriol; 2022 May; 204(5):e0062021. PubMed ID: 35389257
[TBL] [Abstract][Full Text] [Related]
19. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.
Bielaszewska M; Mellmann A; Zhang W; Köck R; Fruth A; Bauwens A; Peters G; Karch H
Lancet Infect Dis; 2011 Sep; 11(9):671-6. PubMed ID: 21703928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
